We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

74 hedge funds and large institutions have $15.8M invested in Ampio Pharmaceuticals Inc. in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

30% more funds holding

Funds holding: 57 → 74 (+17)

23% more call options, than puts

Call options by funds: $744K | Put options by funds: $607K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less capital invested

Capital invested by funds: $19.5M → $15.8M (-$3.78M)

Holders
74
Holders Change
+17
Holders Change %
+29.82%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
22
Reduced
11
Closed
5
Calls
$744K
Puts
$607K
Net Calls
+$137K
Net Calls Change
+$14K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$3.82M
2
State Street
State Street
Massachusetts
+$2.22M
3
Northern Trust
Northern Trust
Illinois
+$1.49M
4
BIT
BlackRock Institutional Trust
California
+$1.2M
5
BIM
BlackRock Investment Management
Delaware
+$567K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$753K
2
KCM
Knoll Capital Management
Florida
-$546K
3
TMC
Trellus Management Company
Florida
-$304K
4
Bank of America
Bank of America
North Carolina
-$298K
5
CP
Camelot Portfolios
Ohio
-$218K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$56K +$158K +145 New
CP
27
Camelot Portfolios
Ohio
$46K -$218K -200 -63%
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$46K +$123K +113 +1,614%
Morgan Stanley
29
Morgan Stanley
New York
$40K – – –
Axa
30
Axa
France
$39K +$110K +101 New
Wells Fargo
31
Wells Fargo
California
$38K +$10.9K +10 +11%
ARTA
32
A.R.T. Advisors
New York
$37K -$77.5K -71 -43%
UBS Group
33
UBS Group
Switzerland
$37K -$28.4K -26 -21%
CS
34
Credit Suisse
Switzerland
$36K -$119K -109 -54%
NFA
35
Nationwide Fund Advisors
Ohio
$36K +$100K +92 New
SB
36
Suntrust Banks
Georgia
$34K – – –
AG
37
Advisor Group
Arizona
$33K +$93.9K +86 New
AIG
38
American International Group
New York
$32.6K -$5.46K -5 -6%
FIM
39
Frontier Investment Management
Texas
$31K – – –
VOYA Investment Management
40
VOYA Investment Management
Georgia
$30K +$83K +76 New
Simplex Trading
41
Simplex Trading
Illinois
$29K +$48.1K +44 +138%
BA
42
BlackRock Advisors
Delaware
$28K +$47K +43 +143%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$26K – – –
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$26K – – –
OC
45
Oppenheimer & Co
New York
$26K – – –
OWP
46
Obermeyer Wealth Partners
Colorado
$25K – – –
JWA
47
JFS Wealth Advisors
Pennsylvania
$23K +$6.55K +6 +11%
GWM
48
Geneos Wealth Management
Colorado
$23K +$10.9K +10 +20%
Millennium Management
49
Millennium Management
New York
$23K +$63.3K +58 New
Brown Advisory
50
Brown Advisory
Maryland
$22K – – –
1
2
3 4

AMPE Hedge Fund Activity: Q2 2016 in Review

74 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2016, worth a combined $15.8M — down 19% from $19.5M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AMPE positions and 5 closed out — a net gain of 18 holders — while 22 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $3.82M. The largest seller was Susquehanna International Group, cutting an estimated $753K.

  • 74 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2016, up from 57 in Q1 2016.
  • Funds reported $15.8M of Ampio Pharmaceuticals Inc. stock for Q2 2016, down 19% quarter-over-quarter.
  • 23 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2016 and 5 closed out, a net change of +18 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $3.82M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2016 was Susquehanna International Group, an estimated $753K sold.

Based on aggregated 13F filings for Q2 2016.